| 1 | TE Teva Pharma Industries Ltd ADR TEVA•US•NYSE $33.94B·$35.84·-1.38% | | $33.94B | $35.84 | -1.38% | 4.7M | |
| 2 | ON ONC•US•NASDAQ $31.55B·$310.75·-0.82% | | $31.55B | $310.75 | -0.82% | 343.4K | |
| 3 | RP RPRX•US•NASDAQ $26.36B·$51.65·+1.83% | | $26.36B | $51.65 | +1.83% | 2.7M | |
| 4 | UT United Therapeutics Corporation UTHR•US•NASDAQ $22.98B·$569.88·-4.50% | | $22.98B | $569.88 | -4.50% | 434.3K | |
| 5 | RO ROIV•US•NASDAQ $19.82B·$28.96·+0.49% | | $19.82B | $28.96 | +0.49% | 4.2M | |
| 6 | GN GNMSF•US•PINK $16.40B·$259.60·-5.60% | | $16.40B | $259.60 | -5.60% | 71 | |
| 7 | GM GMAB•US•NASDAQ $15.50B·$26.18·-6.13% | | $15.50B | $26.18 | -6.13% | 2.6M | |
| 8 | SM SMMT•US•NASDAQ $12.10B·$18.66·+4.54% | | $12.10B | $18.66 | +4.54% | 3.9M | |
| 9 | IO Ionis Pharmaceuticals Inc IONS•US•NASDAQ $11.73B·$75.38·-1.91% | | $11.73B | $75.38 | -1.91% | 1.5M | |
| 10 | MD Madrigal Pharmaceuticals Inc MDGL•US•NASDAQ $10.27B·$497.03·-7.91% | | $10.27B | $497.03 | -7.91% | 305.9K | |
| 11 | PR Praxis Precision Medicines Inc PRAX•US•NASDAQ $8.31B·$331.81·-1.85% | | $8.31B | $331.81 | -1.85% | 651.9K | |
| 12 | NU NUVL•US•NASDAQ $8.31B·$104.55·+0.28% | | $8.31B | $104.55 | +0.28% | 328.9K | |
| 13 | GR GRFS•US•NASDAQ $6.33B·$7.80·-7.25% | | $6.33B | $7.80 | -7.25% | 804.5K | |
| 14 | TE Terns Pharmaceuticals Inc TERN•US•NASDAQ $6.09B·$0.60·-98.87% | | $6.09B | $0.60 | -98.87% | 988.2K | |
| 15 | PT PTCT•US•NASDAQ $5.50B·$76.85·+15.44% | | $5.50B | $76.85 | +15.44% | 3.1M | |
| 16 | XE Xenon Pharmaceuticals Inc XENE•US•NASDAQ $5.20B·$55.78·-4.80% | | $5.20B | $55.78 | -4.80% | 698.4K | |
| 17 | TG TGTX•US•NASDAQ $4.83B·$43.14·+2.79% | | $4.83B | $43.14 | +2.79% | 2.8M | |
| 18 | FO FOLD•US•NASDAQ $4.53B·$14.49·+0.21% | | $4.53B | $14.49 | +0.21% | 5.3M | |
| 19 | LG Ligand Pharmaceuticals Incorporated LGND•US•NASDAQ $4.00B·$220.48·-5.19% | | $4.00B | $220.48 | -5.19% | 197.1K | |
| 20 | IN Indivior PLC Ordinary Shares INDV•US•NASDAQ $3.83B·$38.84·-4.36% | | $3.83B | $38.84 | -4.36% | 2.3M | |
| 21 | VK VKTX•US•NASDAQ $3.76B·$31.72·-1.73% | | $3.76B | $31.72 | -1.73% | 1.9M | |
| 22 | LE LEGN•US•NASDAQ $3.54B·$25.58·-11.67% | | $3.54B | $25.58 | -11.67% | 3.0M | |
| 23 | LQ Liquidia Technologies Inc LQDA•US•NASDAQ $3.13B·$53.13·+26.08% | | $3.13B | $53.13 | +26.08% | 6.9M | |
| 24 | TL Telix Pharmaceuticals Limited TLX•US•NASDAQ $3.02B·$10.83·-2.52% | | $3.02B | $10.83 | -2.52% | 156.4K | |
| 25 | KL Kailera Therapeutics, Inc. Common Stock KLRA•US•NASDAQ $2.97B·$22.93·-7.17% | | $2.97B | $22.93 | -7.17% | 482.9K | |
| 26 | VE VERA•US•NASDAQ $2.92B·$36.61·+0.04% | | $2.92B | $36.61 | +0.04% | 1.1M | |
| 27 | VR Viridian Therapeutics Inc VRDN•US•NASDAQ $2.88B·$17.20·-1.88% | | $2.88B | $17.20 | -1.88% | 3.2M | |
| 28 | TV TVTX•US•NASDAQ $2.81B·$43.51·-2.79% | | $2.81B | $43.51 | -2.79% | 2.4M | |
| 29 | TN TNGX•US•NASDAQ $2.78B·$23.48·-0.59% | | $2.78B | $23.48 | -0.59% | 1.1M | |
| 30 | ID IDYA•US•NASDAQ $2.67B·$28.13·-2.12% | | $2.67B | $28.13 | -2.12% | 980.4K | |
| 31 | IM IMNM•US•NASDAQ $2.31B·$23.00·-1.16% | | $2.31B | $23.00 | -1.16% | 938.7K | |
| 32 | ZL ZLAB•US•NASDAQ $2.30B·$19.59·-6.76% | | $2.30B | $19.59 | -6.76% | 978.9K | |
| 33 | SN Syndax Pharmaceuticals Inc SNDX•US•NASDAQ $2.18B·$21.38·+3.54% | | $2.18B | $21.38 | +3.54% | 2.1M | |
| 34 | ML Mineralys Therapeutics, Inc. Common Stock MLYS•US•NASDAQ $2.18B·$29.73·-1.29% | | $2.18B | $29.73 | -1.29% | 706.3K | |
| 35 | MA Veradermics, Incorporated MANE•US•NYSE $2.17B·$108.13·-1.49% | | $2.17B | $108.13 | -1.49% | 386.7K | |
| 36 | OR ORKA•US•NASDAQ $2.17B·$65.68·-5.89% | | $2.17B | $65.68 | -5.89% | 935.0K | |
| 37 | GL GLPG•US•NASDAQ $2.11B·$27.45·-4.72% | | $2.11B | $27.45 | -4.72% | 194.4K | |
| 38 | NK NKTR•US•NASDAQ $2.07B·$78.72·-7.49% | | $2.07B | $78.72 | -7.49% | 1.5M | |
| 39 | OC OCUL•US•NASDAQ $1.85B·$9.28·-4.43% | | $1.85B | $9.28 | -4.43% | 3.4M | |
| 40 | RA RARE•US•NASDAQ $1.79B·$26.30·+1.43% | | $1.79B | $26.30 | +1.43% | 1.5M | |
| 41 | GE Generate Biomedicines, Inc. Common Stock GENB•US•NASDAQ $1.75B·$14.37·-6.08% | | $1.75B | $14.37 | -6.08% | 358.9K | |
| 42 | ZY Zymeworks Inc. Common Stock ZYME•US•NASDAQ $1.73B·$24.03·-12.97% | | $1.73B | $24.03 | -12.97% | 871.1K | |
| 43 | RA RAPT•US•NASDAQ $1.68B·$58.01·+0.04% | | $1.68B | $58.01 | +0.04% | - | |
| 44 | IN INVA•US•NASDAQ $1.68B·$22.52·+0.00% | | $1.68B | $22.52 | +0.00% | 766.5K | |
| 45 | PV Palvella Therapeutics, Inc PVLA•US•NASDAQ $1.65B·$122.09·-6.21% | | $1.65B | $122.09 | -6.21% | 339.0K | |
| 46 | NR NRIX•US•NASDAQ $1.60B·$16.28·-3.55% | | $1.60B | $16.28 | -3.55% | 636.0K | |
| 47 | HR Harmony Biosciences Holdings HRMY•US•NASDAQ $1.60B·$30.18·-7.93% | | $1.60B | $30.18 | -7.93% | 750.3K | |
| 48 | DM Damora Therapeutics, Inc. DMRA•US•NASDAQ $1.55B·$24.36·-1.34% | | $1.55B | $24.36 | -1.34% | 250.7K | |
| 49 | NU NUVB•US•NYSE $1.47B·$4.76·-5.56% | | $1.47B | $4.76 | -5.56% | 2.0M | |
| 50 | TR TRVI•US•NASDAQ $1.45B·$14.88·+4.35% | | $1.45B | $14.88 | +4.35% | 1.1M | |